$27.01
-0.15-0.54%
At Close: -
$27.26
0.250.91%
After Hours: Jul 17, 9:30 AM EDT
15 minutes delayed
Tema Neuroscience and Mental Health ETF (NASDAQ: MNTL)
Ticker | Name | Share % | |
---|---|---|---|
VRTX | Vertex Pharmaceuticals Inc | 5.43% | |
LLY | Eli Lilly & Co. | 5.26% | |
REGN | Regeneron Pharmaceuticals, Inc. | 4.85% | |
ALNY | Alnylam Pharmaceuticals Inc. | 4.69% | |
BIIB | Biogen Inc. | 4.51% | |
NBIX | Neurocrine Biosciences Inc | 4.40% | |
AS | Argenx Se Spon Adr Each Rep 1 Ord Shs | 4.35% | |
DNLI | Denali Therapeutics Inc | 4.13% | |
SYK | Stryker Corp | 3.67% | |
IL | Teva Pharmaceutical Industries Ltd Sponsored Adr | 3.59% |
The MNTL ETF is currently trading at $27.01, which represents a -0.54% change. Over the past 52 weeks, the ETF has traded as high as $27.50 and as low as $23.67.
The expense ratio of MNTL is 0.75%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for MNTL is 11.91M. This represents the total market value of the assets managed by the ETF.
MNTL follows a Mid Cap Blend investment style.
The top holdings of MNTL include: VRTX (5.43%), LLY (5.26%), REGN (4.85%), ALNY (4.69%), BIIB (4.51%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for MNTL is currently not available.